Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.


Findings from a 3-month, multicenter, retrospective study on Type 2 Diabetes treatment with a tubeless insulin pump, showed:
a. Significant increase in mean HbA1c.
b. No significant change at 3 months from pre-patch pump treatment.
c. A slight reduction in mean HbA1c.
d. A significant reduction in mean HbA1c level of -1.2% (1.4) from baseline on MDI therapy.

Submit
cgmEDUCATION.net is supported by independent educational grants from Ascensia Diabetes Care, Insulet Corporation, Madrigal Pharmaceuticals and Medtronic.
©2022 CogniMed Inc. All rights reserved.